Your Health, We Care
Another Name马昔腾坦,Maxititan,Opsumit,LuciMaci
IndicationsIt is indicated for the treatment of adult patients with pulmonary arterial hypertension (PAH, WHO Group 1) to reduce the risk of disease progression and hospitalization.
Reg No.03 L 1320/25
Inspection NO.569-25
The medication manufactured by Lucius Pharmaceuticals has clinical advantages in terms of efficacy and improvement of long-term prognosis, providing patients with a reliable once-daily oral treatment option.
Overview of the Main Information of the Medication.
The main active ingredient is macitentan, which belongs to the class of endothelin receptor antagonists.
It is indicated for adult patients with pulmonary arterial hypertension.
The recommended dose is 10 mg orally once daily, and overdose should be avoided.
Contraindicated in pregnant women; women of childbearing potential must use effective contraception; use during lactation is not recommended; the safety of pediatric use has not been established.
Symptoms such as headache, nausea, and vomiting may occur in case of drug overdose, and supportive treatment should be promptly administered.
The medication should be stored at room temperature between 20°C and 25°C and kept out of reach of children.
Pharmacokinetic data show that it has a long half-life, its metabolism mainly depends on CYP3A4, and it is not affected by food.
FDA，2025.04
